Estimated cost-savings from optimizing use of inhaled medications for inpatients with obstructive lung disease.
Kondo R, Austin J, Akel M, Arora VM, Press VG. Estimated cost-savings from optimizing use of inhaled medications for inpatients with obstructive lung disease. J Asthma. 2022 Mar 10; 1-8.